# Med Trans EB-5 Fund LLC — Form D

Med Trans EB-5 Fund LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-28. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Investing.

## Offering

- Filed: 2024-02-28
- Form: D
- Accession: 0001766614-24-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Minimum investment: $500K
- Investors: 16
- Date of first sale: 2018-10-26
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-506242

## Issuer

- Name: Med Trans EB-5 Fund LLC
- CIK: 0001766614
- Entity type: Limited Liability Company
- Jurisdiction: NEW YORK
- Address: 232 MADISON AVENUE, NEW YORK, NY, 10016
- Phone: 212-233-7473

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Mehreen Shah | Executive Officer | New York, NY |
| Rebecca S Singh | Executive Officer | New York, NY |

## More

- [CIK 1766614 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1766614&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001766614-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.